Aaron Fong, MD
Dermatology · Honolulu, HINPI 1316478720
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,571 of the $9,272 with a category attached, or 81.7%. 27 manufacturers reported payments, led by UCB, Inc. at 24.2% of the total. 2025 is the largest year on record at $2,370, more than ten times the $147 reported in 2019.
Across 344 payments — averaging $26.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$2K
- AbbVie$1K
- Lilly USA, LLC$795
- LEO Pharma Inc.$630
- Sanofi$599
- Pfizer$537
- plus $3K from 21 others
What the payments were for
- Consulting fees$1,62317%
- Food & beverage$7,57182%
- Education$791%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 24 | $2,247 |
| AbbVie(2 entities) | 64 | $1,348 |
| Lilly USA, LLC | 35 | $795 |
| LEO Pharma Inc. | 35 | $630 |
| Sanofi | 15 | $599 |
| Pfizer | 22 | $537 |
| E.r. Squibb & Sons, L.L.C. | 30 | $480 |
| Regeneron Healthcare Solutions, Inc. | 16 | $449 |
| Amgen | 12 | $305 |
| Galderma Laboratories, L.p. | 20 | $297 |
| Incyte Corporation | 13 | $282 |
| Novartis | 13 | $274 |
| Johnson & Johnson | 8 | $234 |
| Sun Pharmaceutical Industries Inc. | 10 | $202 |
| Dermavant Sciences, Inc. | 4 | $87 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $81 |
| Verrica Pharmaceuticals Inc. | 3 | $77 |
| Almirall LLC | 3 | $61 |
| Genentech USA, Inc. | 2 | $55 |
| Boehringer Ingelheim | 2 | $50 |
| Kyowa Kirin, Inc. | 2 | $41 |
| Journey Medical Corporation | 2 | $35 |
| Organon | 1 | $31 |
| EPI Health, LLC | 1 | $24 |
| Mayne Pharma Commercial LLC | 1 | $24 |
| Biofrontera Inc. | 1 | $15 |
| Arcutis Biotherapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,272 in reported general payments places this provider in the 75th percentile of 67 dermatology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 80 | $4,521 |
| Fluocinonide | 75 | $3,580 |
| Triamcinolone Acetonide | 116 | $1,602 |
| Ketoconazole | 50 | $1,461 |
| Fluorouracil | 17 | $1,252 |
| Halobetasol Propionate | 18 | $753 |
| Metronidazole | 12 | $628 |
| Hydrocortisone | 60 | $543 |
| Mupirocin | 44 | $332 |
| Doxycycline Hyclate | 14 | $256 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Honolulu
- Sarah HowellHonolulu$653K
- Douglas JohnsonHonolulu$568K
- Ryan SatoHonolulu$226K
- Greg SakamotoHonolulu$20K
- Kory KitagawaHonolulu$18K
- Kevin DawsonHonolulu$16K
- Dylan LeeHonolulu$15K
- Sarah GrekinHonolulu$13K
- Gregory HerbichHonolulu$12K
- Stella MatsudaHonolulu$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.